Searcharxiv⌕ Search

arXiv subjects

Pedro Matos-Filipe

Publications and source records attributed to Pedro Matos-Filipe.

2 recordsLinked to original sources

VITAL: A Framework for Validating Agentic AI in Pharmaceutical Drug Development and Clinical Trial Operations

Current assurance approaches do not establish whether evidence is sufficient to validate, monitor and govern agentic artificial intelligence (AI) within a pharmaceutical context of use. Plausible outputs may conceal failures in retrieval, reasoning, orchestration or human-control points, where reference standards are unavailable. We developed and operationalised VITAL (Validation by Intended use, Traceability, Autonomy and Lifecycle evidence), a validation framework for agents in clinical development, through landscape analysis, regulatory and standards mapping, expert interviews and multi-stakeholder refinement. VITAL integrates context of use, controls, behavioural validation and lifecycle evidence within a risk-adjusted framework. We applied VITAL across epidemiology and treatment-landscape analysis, site selection, enrolment rescue and trial-design trade-off support to translate autonomy, reversibility, transparency and patient impact into proportionate validation activities, evidence requirements and auditable reconstruction of system behaviour. VITAL may inform evidence requirements and lifecycle accountability for higher-risk pharmaceutical uses; evaluation should assess reproducibility across assessors, organisations and system configurations.

cs.AI↗

MENSADB: A Thorough Structural Analysis of Membrane Protein Dimers

Membrane Proteins (MPs) account for around 15-39% of the human proteome and assume a critical role in a vast set of cellular and physiological mechanisms, including molecular transport, nutrient uptake, toxin and waste product clearance, respiration, and signaling. While roughly 60% of all FDA-approved drugs target MPs, there is a shortage of structural and biochemical data on them mainly hindered by their localization in the lipid bilayer. We present here MEmbrane protein dimer Novel Structure Analyser database (MENSAdb), a real time web-application exposing a broad array of fundamental features about MPs surface and their interfacial regions. In particular, we present conservation, four distinctive Accessible Solvent Area (ASA) descriptors, average and environment-specific B-factors, intermolecular contacts at 2.5 and 4.0 angstroms distance cutoffs, salt-bridges, hydrogen-bonds, hydrophobic, pi-pi interactions, t-stacking and cation-pi interactions. Additionally, users can closely inspect differences in values between three distinctive residues classes: i) non-surface, ii) surface and non-interfacial and iii) interfacial. The database is freely available at www.moreiralab.com/resources/mensadb.

q-bio.BM↗